Educational Activities Archives

Filter by Target Audience Information
Filter by Target Audience

Please select the option that best aligns with your profession.

Target Audience
Filter by Topic Information
Filter by Topic

Please select the option that best aligns with your topic of interest.

Click on the plus (+) icon to display subtopics.

Training Courses – Full Topics Checkboxes
Filter by Format Information
Filter by Format

Please select the option that best aligns with your preferred format of training.

Formats
Key Term Search Information
Key Term Search

Use the search bar to enter in the title of a training, or other key terms.

Course and Resource Listing

Format: Clinical Tool
Is it appropriate to prescribe buprenorphine monoproduct on a case-by-case basis for the treatment of Opioid Use Disorder for management of patients who experience adverse effects from buprenorphine/naloxone (bup/nx; Suboxone, Zubsolv)?
Credit Available:
CE Credit(s): No
Certificate: No
Format: Clinical Tool
The Collaborative Care Model (CoCM) is an evidence-based approach to deliver behavioral healthcare in primary care settings. This model has been adapted to address substance use disorders in primary medical settings. CoCM requires a team of providers; trained primary care providers (PCP) work with embedded behavioral health care managers (BHCM) to provide a range of effective treatment, including evidence-based medication and/or psychosocial treatments.
Credit Available:
CE Credit(s): No
Certificate: No
Format: Webinar
This presentation will review the Collaborative Care Model (CoCM), which is an evidence-based approach to delivering behavioral healthcare in primary care settings. This model has been adapted to address substance use disorders in primary medical settings. CoCM requires a team of providers; trained primary care providers (PCP) work with embedded behavioral health care managers (BHCM) to provide a range of effective treatments, including evidence-based medication and/or psychosocial treatments, and a psychiatric consultant who engages with the team primarily through indirect care. Implementation and clinical considerations for CoCM for substance use disorders will be reviewed.
Presenter(s):
Anna Ratzliff, MD, PhD; Andrew Saxon, MD; Jasen Christensen, DO
Credit Available:
CE Credit(s): Yes
Designations: AMA PRA Category 1 Creditâ„¢
Format: Clinical Tool
Psychiatric pharmacists are advanced practice clinical pharmacists committed to being part of an interdisciplinary team treating substance use disorders, often in combination with serious mental illness. The following SUD toolkits were developed to further the knowledge of pharmacists and other healthcare professionals.
Credit Available:
CE Credit(s): No
Certificate: No
Format: Clinical Tool
This advisory describes digital therapeutics (DTx) and their use in behavioral health, and benefits of DTx in the prevention, management, and treatment of behavioral health conditions.
Credit Available:
CE Credit(s): No
Certificate: No
Format: Video
This video is from a free online course that aims to improve the care provided to patients that either have or will likely develop substance use disorders.
Presenter(s):
Jeanette Tetrault MD, FACP, FASAM
Credit Available:
CE Credit(s): No
Certificate: No